Immuron Limited
IMRN
$2.23
$0.020.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.05M | 1.03M | 1.30M | 1.34M | 839.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.05M | 1.03M | 1.30M | 1.34M | 839.30K |
| Cost of Revenue | 379.40K | 371.60K | 435.70K | 448.00K | 260.60K |
| Gross Profit | 675.20K | 661.20K | 865.70K | 890.20K | 578.70K |
| SG&A Expenses | 1.31M | 1.28M | 1.26M | 1.29M | 1.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -245.10K | -240.00K | -210.60K | -216.50K | -551.40K |
| Total Operating Expenses | 1.96M | 1.92M | 2.13M | 2.19M | 1.89M |
| Operating Income | -902.60K | -883.90K | -827.20K | -850.50K | -1.05M |
| Income Before Tax | -873.50K | -855.40K | -810.90K | -833.80K | -1.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -873.50K | -855.40K | -810.90K | -833.80K | -1.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -873.50K | -855.40K | -810.90K | -833.80K | -1.60M |
| EBIT | -902.60K | -883.90K | -827.20K | -850.50K | -1.05M |
| EBITDA | -894.60K | -876.70K | -826.20K | -849.60K | -1.05M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 233.35M | 233.35M | 228.53M | 228.53M | 227.92M |
| Average Diluted Shares Outstanding | 233.35M | 233.35M | 228.53M | 228.53M | 227.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |